PRIMA‐1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: The p53 tumour suppressor gene located on chromosome 17p13 is the most frequently mutated gene in human tumours. About 5–8% of cases with acute myeloid leukaemia (AML) carry the p53 mutation. Recently, the compound p53‐dependent reactivation and induction of massive apoptosis (PRIMA‐1) has been shown to induce cytotoxic effects and apoptosis in human tumour cells by restoration of the transcriptional activity of mutated p53. This is believed to be mediated by a change in the conformation of mutated p53 protein, restoring DNA binding and activation of p53 target genes. We studied the effects of PRIMA‐1 and commonly used antileukaemic drugs on AML cells from 62 patients. Cells were obtained from peripheral blood or bone marrow and were exposed to PRIMA‐1, cytarabine, daunorubicin, chlorodeoxyadenosine and fludarabine. This study showed that PRIMA‐1 had cytotoxic effects on AML cells. Conventional AML drugs were less effective in cells with hemizygous p53 deletion. Interestingly, our data indicated that PRIMA‐1 was more effective in this subgroup of patients compared with patients with normal chromosome 17. Our data suggest that the concept of restoration of p53 protein by PRIMA‐1 or a PRIMA‐1‐based new drug may increase the efficacy of AML treatment in patients with p53 mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
Bykov, V. J. N., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K. G., & Selivanova, G. (2002) · Nature Medicine · doi:10.1038/nm0302-282 · Cited by 1,067 · cited 1×
“The mutant p53-dependent effect distinguishes PRIMA-1 from the most commonly used anti-cancer drugs (Bykov et al, 2002a,b).”
BackgroundSelf-citation
Research works printed but not linked: 35
- 10.1038/nm0796-811 · DOI · Paper page
- Andreotti P.E., 1995, Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma, Cancer Research, 55, 5276
- Broxterman H.J., 1997, Transport proteins in drug resistance: detection and prognostic significance in acute myeloid leukemia, Journal of Internal Medicine Supplement, 740, 147, 10.1111/joim.1997.242.s740.147 · doi:10.1111/joim.1997.242.s740.147
- 10.1093/carcin/23.12.2011 · DOI · Paper page
- 10.1182/blood.V79.2.473.473 · DOI · Paper page
- 10.1097/00001813-199906000-00002 · doi:10.1097/00001813-199906000-00002
- 10.1038/35077213 · DOI · Paper page
- Fenaux P., 1991, P53 gene mutations in acute myeloid leukemia with 17p monosomy, Blood, 78, 1652, 10.1182/blood.V78.7.1652.1652 · DOI · Paper page
- 10.1016/S0145-2126(01)00107-2 · DOI
- Gerlach J.H., 1986, Multidrug resistance, Cancer Surveys, 5, 25
- 10.1016/0959-8049(96)00057-3 · DOI · Paper page
- 10.1182/blood.V83.9.2637.2637 · doi:10.1182/blood.v83.9.2637.2637
- 10.1056/NEJM199310283291807 · DOI · Paper page
- 10.1111/j.1365-2141.1992.tb02979.x · DOI · Paper page
- 10.1016/0006-2952(94)00511-J · doi:10.1016/0006-2952(94)00511-j
- Kangas L., 1984, Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro, Medical Biology, 62, 338
- 10.1101/gad.10.9.1054 · DOI · Paper page
- Lai J.L., 1995, Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of P53 mutations, Leukemia, 9, 370
- 10.1128/MCB.6.5.1379 · DOI · Paper page
- 10.1182/blood.V78.3.586.586 · DOI · Paper page
- 10.1111/j.1365-2141.2004.05210.x · DOI · Paper page
- Peng L., 2002, Detection of B lymphoma cells undergoing apoptosis by Annexin‐V assay, Chinese Medical Sciences Journal, 17, 17
- 10.1097/00001813-199709000-00006 · doi:10.1097/00001813-199709000-00006
- 10.1093/jnci/83.10.708 · DOI · Paper page
- 10.1016/0145-2126(93)90011-9 · doi:10.1016/0145-2126(93)90011-9
- 10.1182/blood.V91.3.1008 · DOI · Paper page
- 10.1006/gyno.1995.1190 · DOI
- 10.1182/blood.V97.11.3589 · DOI · Paper page
- 10.1016/0145-2126(93)90022-D · doi:10.1016/0145-2126(93)90022-d
- Tidefelt U., 1992, Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia, Cancer Research, 52, 3281
- 10.1007/s002800050514 · doi:10.1007/s002800050514
- 10.1002/ajh.2830460409 · DOI · Paper page
- Twentyman P.R., 1997, Transport proteins in drug resistance: biology and approaches to circumvention, Journal of Internal Medicine Supplement, 740, 133, 10.1111/joim.1997.242.s740.133 · doi:10.1111/joim.1997.242.s740.133
- 10.1182/blood.V84.9.3148.3148 · DOI · Paper page
- Zochbauer S., 1994, P‐glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia, Leukemia, 8, 974
Cited by
PRIMA-1 reactivates mutant p53 by covalent binding to the core domain
Lambert, J. M. R., Gorzov, P., Veprintsev, D. B., Söderqvist, M., Segerbäck, D., Bergman, J., Fersht, A. R., Hainaut, P., Wiman, K. G., & Bykov, V. J. N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.003 · Cited by 592
Self-citationThe p53 Pathway in Glioblastoma
Zhang, Y., Dube, C., Gibert, M., Cruickshanks, N., Wang, B., Coughlan, M., Yang, Y., Setiady, I., Deveau, C., Saoud, K., et al. (2018) · Cancers · doi:10.3390/cancers10090297 · Cited by 440
Lehmann, S., Bykov, V. J. N., Ali, D., Andrén, O., Cherif, H., Tidefelt, U., Uggla, B., Yachnin, J., Juliusson, G., Moshfegh, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.7783 · Cited by 406
Self-citationFarnebo, M., Bykov, V. J. N., & Wiman, K. G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.152 · Cited by 268
Self-citationAPR-246 induces early cell death by ferroptosis in acute myeloid leukemia
Birsen, R., Larrue, C., Decroocq, J., Johnson, N., Guiraud, N., Gotanegre, M., Cantero-Aguilar, L., Grignano, E., Huynh, T., Fontenay, M., et al. (2021) · Haematologica · doi:10.3324/haematol.2020.259531 · Cited by 182
Metadata
- Authors
- Nahi, H., Merup, M., Lehmann, S., Bengtzen, S., Möllgård, L., Selivanova, G., Wiman, K. G., & Paul, C.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2005-12-09
- Volume
- 132
- Issue
- 2
- Pages
- 230-236
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1965739405
- Cited by
- 62
- References
- 2
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PRIMA‐1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion. https://app.cochat.ai/papers/10.1111/j.1365-2141.2005.05851.x
- The paper
- Nahi, H., Merup, M., Lehmann, S., Bengtzen, S., Möllgård, L., Selivanova, G., Wiman, K. G., & Paul, C. (2006). PRIMA‐1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2005.05851.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.